Erick Lucera

Insider Reports History

Entity
Individual
Location
138 Thistle Road, North Andover, MA
Signature
/s/ Ron Caponigro, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erick Lucera:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Dyne Therapeutics, Inc. Chief Financial Officer Common Stock 66.1K $801K $12.12 Mar 31, 2025 Direct
Editas Medicine, Inc. EVP, CHIEF FINANCIAL OFFICER Common Stock 113K $193K $1.71 Mar 4, 2025 Direct
Beyond Air, Inc. Director Common Stock 43.6K $17.3K $0.40 Aug 14, 2024 Direct
Dyne Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 215K Mar 31, 2025 Direct
Bone Biologics Corp Director Non-Employee Stock Option 85.8K Sep 18, 2023 Direct
Beyond Air, Inc. Director Stock Options (Right to buy) 75K Mar 26, 2025 Direct
Editas Medicine, Inc. EVP, CHIEF FINANCIAL OFFICER Stock Option (right to buy) 70K Mar 8, 2025 Direct
SAB Biotherapeutics, Inc. Director Stock Option (right to buy) 20K Jul 15, 2024 Direct
AVEO PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 0 Jan 19, 2023 Direct

Insider Reports Filed by Erick Lucera

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DYN Dyne Therapeutics, Inc. Mar 31, 2025 2 $0 4 Apr 1, 2025 Chief Financial Officer
DYN Dyne Therapeutics, Inc. Mar 31, 2025 0 $0 3 Apr 1, 2025 Chief Financial Officer
XAIR Beyond Air, Inc. Mar 26, 2025 1 $0 4 Mar 28, 2025 Director
EDIT Editas Medicine, Inc. Mar 8, 2025 2 $0 4 Mar 27, 2025 EVP, CHIEF FINANCIAL OFFICER
EDIT Editas Medicine, Inc. Mar 4, 2025 1 -$7.03K 4 Mar 5, 2025 EVP, CHIEF FINANCIAL OFFICER
XAIR Beyond Air, Inc. Nov 22, 2024 14 $0 4 Nov 26, 2024 Director
XAIR Beyond Air, Inc. Aug 14, 2024 1 $15.6K 4 Aug 15, 2024 Director
SABS SAB Biotherapeutics, Inc. Jul 15, 2024 1 $0 4 Jul 17, 2024 Director
EDIT Editas Medicine, Inc. May 20, 2024 1 -$125K 4 May 22, 2024 EVP, CHIEF FINANCIAL OFFICER
XAIR Beyond Air, Inc. Mar 20, 2024 1 $0 4 Mar 21, 2024 Director
EDIT Editas Medicine, Inc. Mar 2, 2024 3 $0 4 Mar 5, 2024 EVP, CHIEF FINANCIAL OFFICER
BBLG Bone Biologics Corp Sep 18, 2023 1 $0 4 Sep 20, 2023 Director
EDIT Editas Medicine, Inc. May 17, 2023 2 $0 4 May 18, 2023 EVP, CHIEF FINANCIAL OFFICER
EDIT Editas Medicine, Inc. May 17, 2023 0 $0 3 May 18, 2023 EVP, CHIEF FINANCIAL OFFICER
SABS SAB Biotherapeutics, Inc. Apr 3, 2023 1 $0 4 Apr 5, 2023 Director
SABS SAB Biotherapeutics, Inc. Apr 3, 2023 0 $0 3 Apr 5, 2023 Director
XAIR Beyond Air, Inc. Mar 29, 2023 1 $0 4 Mar 31, 2023 Director
XAIR Beyond Air, Inc. Mar 16, 2023 1 $13.6K 4 Mar 20, 2023 Director
AVEO AVEO PHARMACEUTICALS, INC. Jan 19, 2023 3 $0 4 Jan 19, 2023 Chief Financial Officer
BBLG Bone Biologics Corp Aug 23, 2022 1 $0 4 Mar 8, 2023 Director
XAIR Beyond Air, Inc. Mar 3, 2022 1 $0 4 Mar 7, 2022 Director
AVEO AVEO PHARMACEUTICALS, INC. Feb 15, 2022 1 $0 4 Feb 17, 2022 Chief Financial Officer
BBLG Bone Biologics Corp Oct 26, 2021 2 $0 4 Feb 28, 2022 Director
BBLG Bone Biologics Corp Oct 15, 2021 0 $0 3 Oct 21, 2021 Director